Member Info for xviolet

I have never really gone into the details of all this or given it much thought until now but what are the chances of Synairgen achieving a mercanted or pharma-positive set of data-courses . Surely its more probably that while they may develop a product that is efficacious, unwarranted byproducts of standard viral oncology will lead to a much larger redeployment of assets in a tissue-specific or gender-agnostic direction. I wonder if anyone has any thoughts on these issues or how they relate to current NIH and MHRA guidelines. Thank you all.

infestation
plus a few percent down
doesn't it mean a huuuuuuge order being filled.
and trolling to stop everyone else taking advantage of the discount?

well done.
I missed that boat!
close though. :)

you might find trek in iq-ai

its always a positive sign when a bb gets lice
means the property is very very very hot

Thats a lot of £.
Wasn't there an even bigger one a few days ago?
Remember to change the title of the posts....get rid of the cr*p

Utah

Yes. Political.
And increased and presumably long-term focus on vax and therapeutic in case medical/biological reality catches 'em out.

read the first sentence on the new synairgen website:

"We are a specialist respiratory biotech company whose primary focus is developing our investigative Inhaled IFN-ß candidate (SNG001) to meet the urgent need for the treatment of COVID-19 and other severe viral lung infections as potentially the first host-directed, broad-spectrum antiviral treatment delivered directly into the lungs."

To date the management of Synairgen have played - as far as we are aware - a very fair and honest game. They have even, I think, been accused of not being strong, clear, confident or ramp-y enough. There is a reasonable consensus, I think, they are honest and do no mislead people. So that first, clear sentence...that says something.

Was thinking about buying. Noticed the long slide. Then checked this am...suddenly 20% up!

There's your first slide at COPL.
P&Dump or was today's caused by ADV?
John seemed convinced the fundamentals at COPL were sound - I want to buy a few more shares, would have done it today but I was out walking in nature. See what happens Thurs/Fri.

antofelli

think I read something about SA's excess mortality from earlier variants - which effected the mortality/serious illness hit from Omicron. but good luck making sense of all that data. :)

New Syn website intrigues me. Home page talks about Covid and hospitalisations. They have the b*lls to quote Fauci. Do Syn have a deal with the US up their sleeves - regardless of P3? Any guesses? Or do I mis-read the signs.

cheers (with an EISB mixer)

Good RNS today. And still at the beginning of the journey, presumably the best time to get on board.

dixy/wrecked

if you are seriously new to this...normal practice for many is to free ride - buy shares cheap, when they double sell half - the rest are 'free' - take the risk out. but he1 is a bit wild at the moment - so you might let it run if you like more risk (u might want to read about fund-raising and placing) good luck with whatever decision you make.

Unless I've got things wrong its
@ultrabiscuit

I still think its interesting their new website is flagging up words like 'hospitalized patients' and has the b*lls to quote Fauci - if they don't have a deal up their sleeve with the US then they are playing a misleading game. I hold some Synairgen shares - not a vast amount - I guess we shall see.

thanks both.

final market? NBC news:
"Since April 2020, there have been at least 16,800 people hospitalized for Covid in the U.S. over a seven-day period and as many as 156,000, a new peak set Monday. The country across the pandemic has averaged about 60,000 hospitalizations for Covid a day."

Love it. Rig or Big.
HE1 does have these occasional panto elements. Hope no one is in so deep they can't enjoy them.
Good luck all.

One of my other stocks is a small American company. When they announced details of a MOU - it was a relationship with a huge, major much much bigger company. I guess they start with a MOU...then edge towards JV, merger etc - its like the beginning of a long, complex relationship between a minnow and a whale. Don't know if its the same here but if the whale is revealed to be a US oil major...well...happy days :)